Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Year After Acquisition, Perrigo Waits For US Decision On HRA’s OTC Oral Contraceptive Switch

May 11 2023

• By Malcolm Spicer

• Source: Shutterstock

Related Content

Opill AdCom Delay Not Unusual – Will Evaluation Of US OTC Switch Proposal Continue In The Norm?

Nov 03 2022

Room Available In US Pharma Industry For OTC Switch Leader: Has Perrigo Made A Reservation?

Sep 10 2021

HRA Pharma And Maxwellia To Launch The UK’s First OTC Daily Contraceptives

Jul 09 2021

First OTC Oral Contraceptive Has Advisory Panel’s Unanimous Support Despite FDA’s Data Concerns

May 11 2023

Kessler Exits Perrigo With Doors Open On Turnaround, Closed On Ireland, US Tax Disputes

May 10 2023

Reaching 'Transformation' In Turnaround Phase 1, Perrigo Looks To Build On Its Accomplishments

Mar 08 2023

Related Companies

Perrigo Company PLC

Additional Topics

International United States FDA Women's Health Prescription To OTC Switch Advertising, Marketing & Sales Business Strategies Commercial Clinical Trials Companies Compliance Consumer Drug Approval Standards Drug Review Drug Safety Ingredients Manufacturing OTC Drugs Policy Politics Regulation Safety Gynecology & Urology

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window